Suresh R. Mulukutla, MD

Dr. Mulukutla’s research focuses upon racial and ethnic disparities in cardiovascular disease and atherosclerosis. He is funded, in part, by the American Heart Association to study racial differences in metabolism and plaque vulnerability. Dr. Mulukutla also is an active participant in the National Heart, Lung and Blood Institute’s Dynamic Registry of Percutaneous Coronary Intervention, through which he and others study the ever-changing world of coronary revascularization.

Dr. Mulukutla also is the local principal investigator of the Protect II clinical study to evaluate the safety and efficacy of the Impella 2.5 investigational miniature heart pump in patients undergoing high-risk percutaneous coronary interventional procedures. Dr. Mulukutla also is co-director of the UPMC Center for Acute Cardiogenic Shock, which is a coordinated effort among cardiology and cardiac surgery to provide rapid evaluation and therapy to patients who present with cardiogenic shock, a particularly sick patient population.

Dr. Mulukutla, who also is assistant professor of medicine at the University of Pittsburgh School of Medicine, came from Boston University Medical Center (BUMC). He attended medical school at Cornell University Medical College in New York, and completed his residency training at BUMC. In 1999, he joined the University of Pittsburgh as a fellow in cardiovascular research and later completed a fellowship in interventional cardiology at the UPMC Cardiovascular Institute. He also has completed a course in clinical research training at the University of Pittsburgh and is the current holder of a scientist development grant from the American Heart Association.

Dr. Mulukutla’s professional memberships include the American College of Cardiology, the Society of Cardiac Angiography and Interventions, and the Society of Cardiovascular Computed Tomography. He has authored more than a dozen peer-reviewed journal articles, textbook chapters and public abstracts.